Company Page
Telum Therapeutics
Founders
Telum Therapeutics is a global drug discovery biotechnology company based in Navarra, Spain, leveraging synthetic biology, proprietary metagenomic datasets, and generative AI to develop next-generation antimicrobial therapies. Its proprietary APEX platform engineers phage lytic proteins (enzybiotics) designed to precisely target and eliminate multidrug-resistant bacteria, addressing the critical global threat of antimicrobial resistance. The company's lead program targets hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia caused by Acinetobacter baumannii.
Company Founded in 2019
